Brief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
20/10/2026 22:56
BRIEF-Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors Oct 20 (Reuters) - Inhibikase Therapeutics, Inc. IKT.O:
INHIBIKASE THERAPEUTICS APPOINTS SCOTT WASSERMAN TO BOARD OF DIRECTORS
Source text: ID:nGNX9QH9m0
Further company coverage: IKT.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share